Analysis of Intestinal and Nasopharyngeal Microbiota of Children with Meningococcemia in Pediatric Intensive Care

Gurkan Bozan1, Vicente Pérez-Brocal2,3, Kaan Aslan4

  • 1Pediatric Intensive Care Unit, Faculty of Medicine, Eskisehir Osmangazi University, Eskisehir 26040, Turkey.

Insights

This study reveals significant differences in gut and nasopharyngeal microbiota for children with invasive meningococcal disease (IMD). These changes may be linked to the infection or treatments, impacting disease understanding.

Area of Science:

  • Microbiology
  • Pediatric Infectious Diseases
  • Genomics

Background:

  • Microbiota composition is increasingly recognized for its role in sepsis pathophysiology.
  • Invasive meningococcal disease (IMD) is a severe community-acquired infection, yet its association with microbiota in children remains unexplored.
  • Understanding these dynamics is crucial for clinical insights into meningococcemia.

Purpose of the Study:

  • To investigate the intestinal and nasopharyngeal microbiota composition in children diagnosed with IMD.
  • To compare the microbiota of IMD patients with age-matched healthy controls.
  • To analyze changes in microbiota during hospitalization.

Main Methods:

  • Prospective, multi-center study involving 10 children with meningococcemia and 10 healthy controls.
  • Collection of nasopharyngeal and fecal samples at admission and on day 10.
  • 16S rRNA gene sequencing (V3-V4 regions) for microbiota analysis.

Main Results:

  • Significantly lower alpha diversity (Shannon index) in IMD patients compared to controls at admission and day 10 (p=0.002, p=0.001).
  • Distinct differences in fecal microbiota composition between IMD patients and controls (Bray-Curtis, Jaccard analyses; p=0.005, p=0.001).
  • Increased abundance of *Neisseria* in nasopharynx of IMD patients at admission (p<0.001); decreased *Moraxella* and *Neisseria* by day 10. Significant shifts in other genera observed over time.

Conclusions:

  • First evidence of altered intestinal and nasopharyngeal microbiota in children with IMD.
  • Both infection and medical interventions contribute to microbiota alterations during hospitalization.
  • Further research into microbiota-pathogen interactions, like with *N. meningitidis*, can elucidate disease mechanisms.

Related Concept Videos

Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...